Objective: To determine the long-term results of liver transplantation for well- or moderately differentiated hepatocellular carcinoma (HCC). Summary Background Data: HCC patient selection for liver transplantation remains controversial, and deciding exclusively on the strength of criteria such as number and size of nodules appears prognostically inaccurate. Methods: Since 1991, preoperative tumor grading has been used at our center to establish whether a patient with HCC is fit for transplantation. Poorly differentiated HCC cases were excluded, while size and number of nodules were not considered as absolute selection criteria. Thirty-three patients with moderately or well-differentiated HCC were prospectively studied after liver transplantation. A group of 15 patients with incidental HCC transplanted during the same period were also evaluated and compared with the 33 patients with preoperatively diagnosed HCC. Results: On histologic examination, 38% of the entire group of 48 patients did not meet the "Milan criteria" and 42% were pTNM stages III and IV. The median follow-up was 44 months. The 5-year actuarial survival rate was 75% and recurrence-free survival was 92%. HCC recurred in only 3 patients (6%). The only histomorphologic variable differing significantly between incidental and nonincidental HCC was nodule size. The timing of diagnosis (incidental vs. nonincidental HCC), the Milan criteria, and the TNM stage revealed no statistically significant impact on overall and recurrence-free survival rates. Conclusions: The routine pre-orthotopic liver transplantation tumor grading may represent a valid tool in the selection of unresectable HCC patients for transplantation.

Cillo, U., Vitale, A., Bassanello, M., Boccagni, P., Brolese, A., Zanus, G., et al. (2004). Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. ANNALS OF SURGERY, 239(2), 150-159 [10.1097/01.sla.0000109146.72827.76].

Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma

FAGIUOLI S;
2004

Abstract

Objective: To determine the long-term results of liver transplantation for well- or moderately differentiated hepatocellular carcinoma (HCC). Summary Background Data: HCC patient selection for liver transplantation remains controversial, and deciding exclusively on the strength of criteria such as number and size of nodules appears prognostically inaccurate. Methods: Since 1991, preoperative tumor grading has been used at our center to establish whether a patient with HCC is fit for transplantation. Poorly differentiated HCC cases were excluded, while size and number of nodules were not considered as absolute selection criteria. Thirty-three patients with moderately or well-differentiated HCC were prospectively studied after liver transplantation. A group of 15 patients with incidental HCC transplanted during the same period were also evaluated and compared with the 33 patients with preoperatively diagnosed HCC. Results: On histologic examination, 38% of the entire group of 48 patients did not meet the "Milan criteria" and 42% were pTNM stages III and IV. The median follow-up was 44 months. The 5-year actuarial survival rate was 75% and recurrence-free survival was 92%. HCC recurred in only 3 patients (6%). The only histomorphologic variable differing significantly between incidental and nonincidental HCC was nodule size. The timing of diagnosis (incidental vs. nonincidental HCC), the Milan criteria, and the TNM stage revealed no statistically significant impact on overall and recurrence-free survival rates. Conclusions: The routine pre-orthotopic liver transplantation tumor grading may represent a valid tool in the selection of unresectable HCC patients for transplantation.
Articolo in rivista - Articolo scientifico
Liver transplantation; hepatocellular carcinoma;
English
150
159
10
Cillo, U., Vitale, A., Bassanello, M., Boccagni, P., Brolese, A., Zanus, G., et al. (2004). Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. ANNALS OF SURGERY, 239(2), 150-159 [10.1097/01.sla.0000109146.72827.76].
Cillo, U; Vitale, A; Bassanello, M; Boccagni, P; Brolese, A; Zanus, G; Burra, P; Fagiuoli, S; Farinati, F; Rugge, M; D'Amico, D
File in questo prodotto:
File Dimensione Formato  
CILLO ANN SURG 2005.pdf

Solo gestori archivio

Dimensione 390.42 kB
Formato Adobe PDF
390.42 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/353132
Citazioni
  • Scopus 280
  • ???jsp.display-item.citation.isi??? 263
Social impact